ropivacaine hydrochloride - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
NAROPIN 0.2% ropivacaine hydrochloride 40mg/20mL injection ampoule
AUST R: 52405
Active ingredients:
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

From
22 Jul 2025
to
12 Jan 2026

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
An alternative brand is available.
NAROPIN 0.75% ropivacaine hydrochloride 150mg/20mL injection ampoule
AUST R: 52399
Active ingredients:
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

From
22 Jul 2025
to
25 Aug 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Unexpected increase in consumer demand

Management action:
Sponsor is working to expedite the next shipment.
ROPIBAM 0.2% Ropivacaine hydrochloride 400mg/200mL solution for injection bag
AUST R: 186571
Active ingredients:
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Boucher & Muir Pty Ltd

Phone:
1800 627 680

From
11 Nov 2024
to
31 Dec 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.
ROPIVACAINE KABI ropivacaine hydrochloride 150 mg/20 mL solution for injection ampoule
AUST R: 195807
Active ingredients:
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Fresenius Kabi Australia Pty Ltd

Phone:
02 9391 5555

From
16 Jul 2025
to
15 Sep 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Transport / Logistic issues / Storage capacity issues

Management action:
Sponsor is working to expedite the next shipment. Other strengths are available.
ROPIVACAINE KABI ropivacaine hydrochloride 40 mg/20 mL solution for injection ampoule
AUST R: 195804
Active ingredients:
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Fresenius Kabi Australia Pty Ltd

Phone:
02 9391 5555

From
21 Jul 2025
to
15 Sep 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Transport / Logistic issues / Storage capacity issues

Management action:
An alternative brand is available.
NAROPIN 0.2% ropivacaine hydrochloride 200mg/100mL injection bag
AUST R: 52396
Active ingredients:
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

Deletion from market:
30 Jun 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.
NAROPIN 0.2% ropivacaine hydrochloride 400mg/200mL injection bag
AUST R: 52395
Active ingredients:
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

Deletion from market:
06 Feb 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.
NAROPIN 0.2% WITH FENTANYL 200 microgram/100mL ropivacaine hydrochloride 2mg/mL and fentanyl 2 microgram/mL (as citrate) 100mL injection bag
AUST R: 72874
Active ingredients:
fentanyl citrate
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

Deletion from market:
20 Mar 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative presentations of the active ingredients are available.
NAROPIN 0.2% WITH FENTANYL 400 microgram/100mL ropivacaine hydrochloride 2 mg/mL and fentanyl 4 microgram/mL (as citrate) 100ml injection bag
AUST R: 72876
Active ingredients:
fentanyl citrate
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

Deletion from market:
06 Feb 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative presentations of the active ingredients are available.
NAROPIN 0.2% WITH FENTANYL 400 microgram/200mL ropivacaine hydrochloride 2 mg/mL and fentanyl 2 microgram/mL (as citrate) 200mL injection bag
AUST R: 72873
Active ingredients:
fentanyl citrate
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300

Deletion from market:
01 May 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative presentations of the active ingredients are available.
NAROPIN 0.2% WITH FENTANYL 800 microgram/200mL ropivacaine hydrochloride 2 mg/mL and fentanyl 4 microgram/mL (as citrate) 200mL injection bag
AUST R: 72875
Active ingredients:
fentanyl citrate
ropivacaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

Deletion from market:
06 Feb 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative presentations of the active ingredients are available.